Search results
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters· 8 hours ago, opens new tab was widely used during the pandemic, said on Monday that almost all of its expected...
Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Medical Xpress· 5 days agoPharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 5 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer gained through its $43 billion deal...
What's Going With BioNTech Stock On Monday?
Benzinga via AOL· 3 hours agoMonday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the...
Pfizer profits drop on lower Covid-19 product sales
Digital Journal· 5 days agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
Earnings call: Pfizer raises 2024 EPS outlook despite revenue decline By Investing.com
Investing.com· 5 days agoDespite a 19% decline in total company revenues to $14.9 billion, primarily due to the reduced...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 5 days agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 5 days agoThat was partly due to a one-time $771 million infusion after the U.S. government returned 5.1...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 5 days agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...
Pfizer Stock Rises as Outlook Rises After Earnings Beat
Barrons.com· 5 days agoPfizer bumped up its earnings guidance on Wednesday while reporting better financial results than...